NLRP3 and diabetes mellitus: In the development of glucotoxicity in diabetes, endogenous glutamate aggravates the high-glucose-induced β-cells dysfunction via excessive activation of NMDA receptors on β-cells, leading to activation of NF-κB and NLRP3 inflammasomes.